Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis

World Journal of Gastroenterology

Volumn 12, Issue 10, 2006, Pages 1607-1612

  Biagini, Maria Rosa ^a   Tozzi, Alessandro ^a   Marcucci, Rossella ^a   Paniccia, Rita ^a   Fedi, Sandra ^a   Milani, Stefano ^a   Galli, Andrea ^a   Ceni, Elisabetta ^a   Capanni, Marco ^a   Manta, Raffaele ^a   Abbate, Rosanna ^a   Surrenti, Calogero ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Folic acid; Homocysteinemia; Hypercoagulability; Primary biliary cirrhosis; Tissue factor

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; CYANOCOBALAMIN; D DIMER; FIBRINOGEN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PYRIDOXINE; THROMBIN ANTITHROMBIN COMPLEX; THROMBOMODULIN; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HEMOSTASIS; HOMOZYGOSITY; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PROTHROMBIN TIME; THROMBOCYTE FUNCTION; VITAMIN DEFICIENCY;

EID: 33645744715     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i10.1607     Document Type: Article

References (42)

1. Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003; 362: 53-61
2. Kaplan MM. Primary biliary cirrhosis: past, present, and future. Gastroenterology 2002; 123: 1392-4139
3. Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OF. Natural history of early primary biliary cirrhosis. Lancet 1996; 348: 1399-1402
4. Shannon P, Wanless IR. Hepatology 1995 vol. 22 N.4 Pt. 2 A585
5. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995; 21: 1238-1247
6. Wanless IR, Liu JJ, Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 1995; 21: 1232-1237
7. Papatheodoridis GV, Papakonstantinou E, Andrioti E, Cholongitas E, Petraki K, Kontopoulou I, Hadziyannis SJ. Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut 2003; 52: 404-409
8. Ben-Ari Z, Panagou M, Patch D, Bates S, Osman E, Pasi J, Burroughs A. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol 1997; 26: 554-559
9. Pihusch R, Rank A, Gohring P, Pihusch M, Hiller E, Beuers U. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease. J Hepatol 2002; 37: 548-555
10. Garcia-Tevijano ER, Berasain C, Rodriguez JA, Corrales FJ, Arias R, Martin-Duce A, Caballeria J, Mato JM, Avila MA. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis. Hypertension 2001; 38: 1217-1221
11. Coppola A, Davi G, De Stefano V, Mancini FP, Cerbone AM, Di Minno G. Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 2000; 26: 243-254
12. Ben-Ari Z, Tur-Kaspa R, Schafer Z, Baruch Y, Sulkes J, Atzmon O, Greenberg A, Levi N, Fainaru M. Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with chronic liver disease. J Investig Med 2001; 49: 325-329
13. Abbate R, Sardi I, Pepe G, Marcucci R, Brunelli T, Prisco D, Fatini C, Capanni M, Simonetti I, Gensini GF. The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD). Thromb Haemost 1998; 79: 727-730
14. Gores GJ, Wiesner RH, Dickson ER, Zinsmeister AR, Jorgensen RA, Langworthy A. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival. Gastroenterology 1989; 96: 1552-1559
15. Biagini MR, Guardascione M, McCormick AP, Raskino C, McIntyre N, Burroughs AK. Bleeding varices in PBC and its prognostic significance. Gut 1990: A1209
16. Coppola A, Davi G, De Stefano V, Mancini FP, Cerbone AM, Di Minno G. Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 2000; 26: 243-254
17. Popov S, Kalinke H, Etzel F. Coagulation changes during and after liver transplantation in man. In: Von Kala KN, ed Coagulation in transplanted organs. Springfield, Illinois: Charles C. Thomas 1975: 31-51
18. Ritter DM, Owen CA Jr, Bowie EJ, Rettke SR, Cole TL, Taswell HF, Ilstrup DM, Wiesner RH, Krom RA. Evaluation of preoperative hematology-coagulation screening in liver transplantation. Mayo Clin Proc 1989; 64: 216-223
19. Mallett SV, Cox DJ. Thrombelastography. Br J Anaesth 1992; 69: 307-313
20. Palareti G, Legnani C, Maccaferri M, Gozzetti G, Mazziotti A, Martinelli G, Zanello M, Sama C, Coccheri S. Coagulation and fibrinolysis in orthotopic liver transplantation: role of the recipient's disease and use of antithrombin III concentrates. S. Orsola Working Group on Liver Transplantation. Haemostasis 1991; 21: 68-76
21. Kew MC, Varma RR, Dos Santos HA, Scheuer PJ, Sherlock S. Portal hypertension in primary biliary cirrhosis. Gut 1971; 12: 830-834
22. Duplantier JG, Dubuisson L, Senant N, Freyburger G, Laurendeau I, Herbert JM, Desmouliere A, Rosenbaum J. A role for thrombin in liver fibrosis. Gut 2004; 53: 1682-7
23. Nemerson Y. Tissue factor: then and now. Thromb Haemost 1995; 74: 180-184
24. Jude B, Fontaine P. Modifications of monocyte procoagulant activity in diabetes mellitus. Semin Thromb Hemost 1991; 17: 445-447
25. Akbar SM, Yamamoto K, Miyakawa H, Ninomiya T, Abe M, Hiasa Y, Masumoto T, Horiike N, Onji M. Peripheral blood T-cell responses to pyruvate dehydrogenase complex in primary biliary cirrhosis: role of antigen-presenting dendritic cells. Eur J Clin Invest 2001; 31: 639-646
26. Kita H, Lian ZX, Van de Water J, He XS, Matsumura S, Kaplan M, Luketic V, Coppel RL, Ansari AA, Gershwin ME. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med 2002; 195: 113-123
27. Egerton W, Silberberg J, Crooks R, Ray C, Xie L, Dudman N. Serial measures of plasma homocyst(e)ine after acute myocardial infarction. Am J Cardiol 1996; 77: 759-761
28. Lindgren A, Brattstrom L, Norrving B, Hultberg B, Andersson A, Johansson BB. Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 1995; 26: 795-800
29. Colli S, Eligini S, Lalli M, Camera M, Paoletti R, Tremoli E. Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis. Arterioscler Thromb Vase Biol 1997; 17: 265-272
30. Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y. The plasminogen activator system: biology and regulation. Cell Mol Life Sci 1999; 56: 104-132
31. Stanger O. Physiology of folic acid in health and disease. Curr Drug Metab 2002; 3: 211-223
32. Elsborg L, Larsen L. Folate deficiency in chronic inflammatory bowel diseases. Scand J Gastroenterol 1979; 14: 1019-1024
33. Franklin JL, Rosenberg HH. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine). Gastroenterology 1973; 64: 517-525
34. Steinberg SE, Campbell CL, Hillman RS. Effect of alcohol on tumor folate supply. Biochem Pharmacol 1982; 31: 1461-1463
35. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113
36. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997; 90: 1-11
37. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48: 536-545
38. Longo M, Crosignani A, Battezzati PM, Squarcia Giussani C, Invernizzi P, Zuin M, Podda M. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 2002; 51: 265-269
39. Crippin JS, Lindor KD, Jorgensen R, Kottke BA, Harrison JM, Murtaugh PA, Dickson ER. Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk? Hepatology 1992; 15: 858-862
40. Olszewski AJ, McCully KS. Homocysteine content of lipoproteins in hypercholesterolemia. Atherosclerosis 1991; 88: 61-68
41. McCully KS, Olszewski AJ, Vezeridis MP. Homocysteine and lipid metabolism in atherogenesis: effect of the homocysteine thiolactonyl derivatives, thioretinaco and thioretinamide. Atherosclerosis 1990; 83: 197-206
42. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, Austin RC. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001; 107:1263-1273